Related Experiment Video
Updated: Aug 8, 2025

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Ras protein abundance correlates with Ras isoform mutation patterns in cancer
Fiona E Hood1, Yasmina M Sahraoui1, Rosalind E Jenkins2
1Department of Molecular Physiology and Cell Signalling, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, L69 3BX, UK.
Abstract:
Activating mutations of Ras genes are often observed in cancer. The protein products of the three Ras genes are almost identical. However, for reasons that remain unclear, KRAS is far more frequently mutated than the other Ras isoforms in cancer and RASopathies. We have quantified HRAS, NRAS, KRAS4A and KRAS4B protein abundance across a large panel of cell lines and healthy tissues. We observe consistent patterns of KRAS > NRAS»HRAS protein expression in cells that correlate with the rank order of Ras mutation frequencies in cancer. Our data provide support for the model of a sweet-spot of Ras dosage mediating isoform-specific contributions to cancer and development. We suggest that in most cases, being the most abundant Ras isoform correlates with occupying the sweet-spot and that HRAS and NRAS expression is usually insufficient to promote oncogenesis when mutated. However, our results challenge the notion that rare codons mechanistically underpin the predominance of KRAS mutant cancers. Finally, direct measurement of mutant versus wildtype KRAS protein abundance revealed a frequent imbalance that may suggest additional non-gene duplication mechanisms for optimizing oncogenic Ras dosage.
Insights
Higher KRAS protein levels, not rare codons, may explain its frequent mutation in cancer. This Ras dosage sweet-spot model impacts cancer and development.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Activating Ras gene mutations are common in cancer.
- KRAS is mutated more frequently than HRAS and NRAS in cancer and RASopathies, but the reasons are unclear.
- The protein products of Ras genes are nearly identical.
Purpose of the Study:
- To quantify HRAS, NRAS, KRAS4A, and KRAS4B protein abundance in cell lines and tissues.
- To investigate the correlation between Ras isoform protein expression and mutation frequencies in cancer.
- To explore the role of Ras dosage in cancer development and isoform-specific contributions.
Main Methods:
- Quantitative analysis of HRAS, NRAS, KRAS4A, and KRAS4B protein levels.
- Comparison of protein abundance across diverse cell lines and healthy tissues.
- Correlation analysis with known Ras mutation frequencies in various cancers.
Main Results:
- Consistent KRAS > NRAS > HRAS protein expression patterns were observed.
- These expression patterns correlate with the rank order of Ras mutation frequencies in cancer.
- Mutant vs. wild-type KRAS protein abundance showed frequent imbalance, suggesting non-gene duplication mechanisms.
Conclusions:
- Ras protein dosage, particularly high KRAS levels, may define a 'sweet-spot' influencing cancer and development.
- High abundance of KRAS, rather than rare codons, likely underlies its predominant mutation in cancer.
- Isoform-specific Ras dosage contributes to oncogenesis, with HRAS and NRAS typically insufficient for transformation when mutated.
More Related Videos
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
06:44Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
Published on: March 1, 2024
Related Concept Videos
The Ras Gene
Ras is a...
Abnormal Proliferation
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
MAPK Signaling Cascades